Vtcn1 - V-set domain containing T cell activation inhibitor 1

Predicted to enable signaling receptor binding activity. Predicted to be involved in several processes, including T cell receptor signaling pathway; negative regulation of T cell proliferation; and negative regulation of apoptotic process. Predicted to act upstream of or within positive regulation of interleukin-2 production; regulation of T cell activation; and response to protozoan. Predicted to be anchored component of membrane. Predicted to be active in external side of plasma membrane. Orthologous to human VTCN1 (V-set domain containing T cell activation inhibitor 1). [provided by Alliance of Genome Resources, Apr 2022]